Patients with heterozygous mutations in JUP have been diagnosed with HCM [22,23], and reduced cardiac DSG2 levels appear to be specifically associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) [24]. Here, DSG2 is linked to arrhythmogenic right ventricular cardiomyopathy.